← Evidence map

ArticleDermatology and therapy2026

Real-World Effectiveness and Safety of 12 Months of Tralokinumab in Patients with Atopic Dermatitis.

April W Armstrong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42622791